Evidence map›Paper›PMID 40032845›Full record

ArticleBDJ open2025

In vitro evaluation of human enamel remineralization after treatment with Ginger, Ashwaganda and Maca herbal dentifrices versus commercially available fluoride containing dentifrice.

Ghada Ahmed Elzayat, Fagr Hassan Elmergawy, Aya Abd ElFattah Mohammed Nemt Allah

Abstract read
In one paragraph

Article in BDJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ghada Ahmed ElzayatLecturer of Conservative dentistry, Faculty of Dentistry, Egyptian Russian University, Cairo, Egypt.
Fagr Hassan ElmergawyLecturer of Dental Biomaterials, Faculty of Dentistry, October university for modern sciences and arts (MSA), Giza, Egypt. fagrmergawy@gmail.com.ORCID http://orcid.org/0000-0003-1514-4851
Aya Abd ElFattah Mohammed Nemt AllahLecturer of Conservative dentistry, Faculty of Dentistry, Egyptian Russian University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCompare the remineralization efficiency of Ginger, Ashwaghanda and Maca dentifrices versus commercially fluoride containing dentifrice.

methodsGinger, Ashwaghanda and Maca extracts were prepared by solvent extraction methodology and were characterized using transmission electron microscope, dynamic light scattering, and inductively coupled plasma optical emission spectrometer. The pH of the dentifrices was evaluated by pH meter. Eighty teeth were collected and divided into five groups according to the treatment protocol. Enamel morphology was carried out by scanning electron microscope with energy dispersive X-Ray spectroscopy for the analysis of calcium, phosphorus, Ca/P ratio and carbon. Surface microhardness was evaluated by Vickers micro-hardness tester. Data were analyzed using One-way ANOVA followed by Tukey's post hoc test (p ≤ 0.05).

resultsCharacterization results showed the highest calcium, phosphorus and fluoride ion release were associated to Maca, Ashwaganda and Ginger respectively. The pH results revealed that Ginger dentifrice exhibited the most alkaline pH, whereas Ashwaganda dentifrice exhibited the most acidic pH. Morphological analysis revealed that Ashwaganda showed lower remineralization ability compared to the other treated groups. Maca showed significant higher Ca/P ratio compared to other groups (p < 0.001) and Ginger showed significant higher surface microhardness recovery compared to Ashwaganda (p < 0.001).

conclusionGinger and Maca are promising remineralizing agents.

Identifiers

PMID40032845
PMCPMC11876320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.